Relay Therapeutics to Host New Program and Platform Event on June 6, 2024
CAMBRIDGE, Mass., May 13, 2024 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq:RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that the company will host a New Program and Platform event on Thursday, June 6, 2024 from 8:00 to 10:00 a.m. ET. During the event, the company will disclose new programs from its existing pre-clinical pipeline and review how the Dynamo™ platform led to these novel discoveries.